Highlights and Quick Summary
- SG&A Expenses for the quarter ending September 30, 2022 was $211 Thousand (a -0.19% decrease compared to previous quarter)
- Year-over-year quarterly SG&A Expenses decreased by -28.51%
- Annual SG&A Expenses for 2021 was $1.54 Million (a 516.95% increase from previous year)
- Annual SG&A Expenses for 2020 was $249 Thousand (a 0.0% decrease from previous year)
- Twelve month SG&A Expenses ending September 30, 2022 was $980 Thousand (a -24.27% decrease compared to previous quarter)
- Twelve month trailing SG&A Expenses decreased by -36.17% year-over-year
Trailing SG&A Expenses for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
$980 Thousand | $1.29 Million | $1.44 Million | $1.54 Million |
Visit stockrow.com/PHIC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical SG&A Expenses of Population Health Investment Co., Inc.
Most recent SG&A Expensesof PHIC including historical data for past 10 years.Interactive Chart of SG&A Expenses of Population Health Investment Co., Inc.
Population Health Investment Co., Inc. SG&A Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $0.21 | $0.21 | $0.26 | – |
2021 | $0.3 | $0.53 | $0.35 | $0.36 | $1.54 |
2020 | $0.22 | $0.03 | – | – | $0.25 |
Business Profile of Population Health Investment Co., Inc.
Sector: Financial Services
Industry: Shell Companies